# US 2025/0320446 A1 · Method and system for providing buffer solutions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0320446 A1
- Document ID: US20250320446A1
- Status: Published application
- Kind: A1
- Application number: 19/247,061
- Filed: 2025-06-24
- Published: 2025-10-16
- Earliest claimed: 2016-08-02
- Assignees: Lonza Ltd.
- Applicants: Lonza Ltd
- Inventors: Tristan WILKINS
- Web page: https://patentgrep.com/patent/US20250320446A1

## CPC

- C12M 41/32: {of substances in solution}
- C12M 23/44: {Multiple separable units; Modules}
- C12M 29/00: {Means for introduction, extraction or recirculation of materials, e.g. pumps (pumps per se F04B)}
- C12M 37/00: {Means for sterilizing, maintaining sterile conditions or avoiding chemical or biological contamination (C12M23/38 takes precedence; filtration in general and filters per se B01D24/00-B01D41/00; autoclaves B01J3/04; treatment of microorganisms with electrical or wave energy C12N13/00)}
- C12M 41/36: {of biomass, e.g. colony counters or by turbidity measurements (electrooptical investigation of individual particles G01N15/14, flow cytometers G01N15/1404)}
- C12M 43/00: {Combinations of bioreactors or fermenters with other apparatus}
- B67D 7/0294: {Combined with valves}
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- B67D: DISPENSING, DELIVERING OR TRANSFERRING LIQUIDS, NOT OTHERWISE PROVIDED FOR (cleaning pipes or tubes or systems of pipes or tubes B08B9/02; emptying or filling of bottles, jars, cans, casks, barrels, or similar containers, not otherwise provided for B67C; water supply E03; pipe systems F17D; domestic hot-water supply systems F24D; measuring volume, volume flow, mass flow or liquid level, metering by volume G01F; coin-freed or like apparatus G07F)

## Abstract

A method for delivering a processing solution includes providing a concentrated processing solution in a bioprocess container, the concentrated processing solution being produced at a first site. The method also includes combining the concentrated processing solution with a biopolymer containing solution produced in a bioreactor at a second site different from the first site. In some embodiments, the processing solution is a buffer for processing products of cells cultured in a bioreactor. A system and a pharmaceutical production facility for carrying out the method is also provided.

## Claims

### Claim 1

A method for delivering a processing solution, the method comprising:
providing a concentrated processing solution in a bioprocess container, the concentrated processing solution being produced at a first site;
transporting the bioprocess container containing the processing solution from the first site to a second site different from the first site;
fluidly connecting the bioprocess container to a bioreactor at the second site via a pipe; and
combining the concentrated processing solution with a biopolymer-containing solution produced in the bioreactor at the second site,
wherein the processing solution is at least one of a buffer and media.

### Claim 2 (depends on 1)

The method of claim 1, wherein the concentrated processing solution is provided based on a determination that the concentrated processing solution is required and the determination is communicated from the second site to the first site.

### Claim 3 (depends on 1)

The method of claim 1, further comprising diluting the concentrated processing solution prior to combining with the biopolymer-containing solution.

### Claim 4 (depends on 1)

The method of claim 1, wherein the processing solution is one of Tris, Tris-Base, Tricine, HEPES, MOPS, PIPES, TAPS, bicine, BES, TES, cacodylate, MES, acetate, MKP, ADA, ACES, glycinamide, acetamidoglycine, acetic acid, citric acid, glycine, glycine glycinate, sodium phosphate, ethanol, hydrochloric acid, sodium hydroxide, guanidinium chloride, guanidine hydrochloride, sodium chloride, and a combination of any of these.

### Claim 5 (depends on 1)

The method of claim 1, further comprising determining a bioburden of the processing solution.

### Claim 6 (depends on 1)

The method of claim 1, further comprising: maintaining, via a valve connected to the pipe, a sterile condition of the bioreactor when the bioprocess container is disconnected from the pipe.

### Claim 7 (depends on 1)

The method of claim 1, wherein the first site does not include a bioreactor.

### Claim 8 (depends on 1)

The method of claim 1, wherein the second site is a GMP pharmaceutical production facility.

### Claim 9 (depends on 1)

The method of claim 1, further comprising tracking the bioprocess container via an RFID tag on the bioprocess container.

### Claim 10 (depends on 1)

The method of claim 1, wherein the biopolymer-containing solution comprises a biopolymer made from a Chinese hamster ovary (CHO) cell.

### Claim 11 (depends on 1)

The method of claim 1, wherein the biopolymer-containing solution comprises a biopolymer which is a hormone, a blood-clotting factor, a growth factor, an antibody, or a fusion protein.

### Claim 12 (depends on 11)

The method of claim 11, wherein the biopolymer is a bispecific antibody.

### Claim 13 (depends on 5)

The method of claim 5, wherein the bioburden is determined at the first site or at the second site.
